Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 266-658-8 | CAS number: 67352-37-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Gene mutation assays in bacteria: A modified AMES test is in progress and expercted to be negative.
An AMES test on a similar substance resulted negative
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Mutagenicity testing strategy is reported in ECHA Guidance Chapter R.7a: Endpoint specific guidance, Version 4.0 – July 2015.
A preliminary assessment of mutagenicity should normally includes data from a gene mutation test in bacteria unless existing data for analogous substances indicates this would be inappropriate.
When the result of the bacterial test is positive, it is important to consider the possibility of the substance being genotoxic in mammalian cells.
In order to ensure the necessary minimum level of information is provided, at least a further test is required in addition to the gene mutation test in bacteria. This should be an in vitro mammalian cell test capable of detecting both structural and numerical chromosome aberrations. A suitable option is in vitro chromosome aberration test (OECD guideline 473), i.e. a cytogenetic assay for structural chromosome aberrations using metaphase analysis.
An in vitro gene mutation study in mammalian cells (OECD guideline 476) is the second part of the standard information set usually required, when the results of the bacterial gene mutation test and the first study in mammalian cells (i.e. an in vitro chromosome aberration test or an in vitro micronucleus test) are negative. This is to detect in vitro mutagens that give negative results in the other tests.
Substances for which mammalian cell tests are negative while bacterial test is positive should be evaluated for any further testing on a case-by-case basis. If available, an in vivo test may be used in the assessment.
In general, substances that are positive in the gene mutation test in bacteria, negative in in vitro tests of chromosome aberration or micronucleus and negative in an in vivo test, e.g. micronucleus test, are considered to be non-genotoxic.
No information was available on the substance itself, i.e Solvent Orange 062 acid, thus the assessment relied on a read across approach. In particular, Solvent Orange 062 sodium salt, containing some amounts of its acid form was used as read across substances. Solvent Orange 062 is a chromium complex with 2 ligands. The 2 ligands have the same chemical structure, i.e. a phenyl ring connected via diazo bond to a phenyl pyrazole. These ligands show minor differences in the position of substituents, i.e. hydroxy and nitro gorups.
All information about the read across choice is inserted in section 13.
T read across substance was evaluated for the potential mutagenic activity in the plate incorporation AMES assay. A study was performed on Solvent Orange 062 sodium salt. In particular, 5 different strains, namely TA 98, TA 100, TA 1535, TA 1537 and TA 1538, were tested in the plate incorporation test in presence and in absence of metabolic activation (S9 mix). Tested doses were 1.58, 5, 15.8, 50, 158, 500, 1580 and 5000 µg/plate and each of them, including controls, was tested in triplicate. Positive and negative control results were valid. No toxic effects were noted up to the highest concentration.
No sign of mutagenic activity of test substance was reported.
Justification for classification or non-classification
According to the CLP Regulation (EC n. 1272/2008), Annex I, Part 3, substances which cause concern for humans owing to the possibility that they may induce heritable mutations in the germ cells of humans are classified in Category 2. This classification is based on positive evidence obtained in:
— somatic cell mutagenicity tests in vivo, in mammals; or
— other in vivo somatic cell genotoxicity tests which are supported by positive results from in vitro mutagenicity assays.
Note: substances which are positive in in vitro mammalian mutagenicity assays, and which also show chemical structure activity relationship to known germ cell mutagens, shall be considered for classification as Category 2 mutagens.
In vitro mutagenicity tests are the following:
— in vitro mammalian chromosome aberration test;
— in vitro mammalian cell gene mutation test;
— bacterial reverse mutation tests.
The overall assessement on the genotoxic potential of test substance was based on: negtaive outcomes in bacterial reverse mutation assay (AMES test) based on similar substance and the expected negative results of AMES test which is in progress.
All studies were conducted according to OECD guidelines and have a high reliability. Differences with respect to current versions of guidelines, do not significantly influence the overall evaluation, which was thus taken as valid and reliable.
Based on these results, which fulfil the mutagenicity testing strategy required by Annex VII and VIII of the REACH Regulation (EC n. 1907/2006), the test susbstance was considered as non genotoxic and it was not classified within the CLP Regulation (EC n. 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.